Nanologica AB - Asset Resilience Ratio

Latest as of September 2022: 1.14%

Nanologica AB (NICA) has an Asset Resilience Ratio of 1.14% as of September 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Nanologica AB (NICA) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Skr1.05 Million

≈ $113.00K USD Cash + Short-term Investments

Total Assets

Skr91.75 Million

≈ $9.87 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2024)

This chart shows how Nanologica AB's Asset Resilience Ratio has changed over time. See what is Nanologica AB's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Nanologica AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NICA company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr1.05 Million	1.14%
Total Liquid Assets	Skr1.05 Million	1.14%

Asset Resilience Insights

Limited Liquidity: Nanologica AB maintains only 1.14% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Nanologica AB Industry Peers by Asset Resilience Ratio

Compare Nanologica AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for Nanologica AB (2018–2024)

The table below shows the annual Asset Resilience Ratio data for Nanologica AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.00%	Skr-1.00K ≈ $-107.62	Skr143.10 Million ≈ $15.40 Million	-0.73pp
2021-12-31	0.73%	Skr714.00K ≈ $76.84K	Skr98.32 Million ≈ $10.58 Million	-0.38pp
2020-12-31	1.10%	Skr1.61 Million ≈ $173.80K	Skr146.34 Million ≈ $15.75 Million	+1.10pp
2019-12-31	0.00%	Skr1.00 ≈ $0.11	Skr42.29 Million ≈ $4.55 Million	0.00pp
2018-12-31	0.00%	Skr1.00 ≈ $0.11	Skr34.33 Million ≈ $3.69 Million	--

pp = percentage points

About Nanologica AB

ST:NICA Sweden Biotechnology

Market Cap

$5.12 Million

Skr47.60 Million SEK

Market Cap Rank

#28320 Global

#640 in Sweden

Share Price

Skr0.53

Change (1 day)

+0.75%

52-Week Range

Skr0.35 - Skr1.98

All Time High

Skr19.15